Nilotinib Capsule
Product Images NDC 31722-780

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 31722-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nilotinib150mgwalletcarton (Nilotinib150mgwalletcarton)

Nilotinib150mgwalletcarton (Nilotinib150mgwalletcarton)
Carton for Nilotinib Capsules 150 mg by Camber Pharmaceuticals, Inc. The packaging indicates oral capsule form with 4 individual blister packs, each containing 28 capsules. The label includes dosage strength 150 mg per capsule, warnings about empty stomach administration, child-resistant packaging, and contact information for the manufacturer. The label also notes the need to dispense a separate Medication Guide with the product.*
FDA Label Image

Nilotinib150mgwalletpack (Nilotinib150mgwalletpack)

Nilotinib150mgwalletpack (Nilotinib150mgwalletpack)
The image shows the packaging label for Nilotinib 150 mg capsules by Camber Pharmaceuticals, Inc. It includes detailed folding lines for a carton with tear strips labeled for opening. The label highlights the proprietary name Nilotinib, dosage strength of 150 mg per capsule, and provides patient guidance instructions. The packaging also contains visual instructions and a barcode, along with manufacturer information and patient safety notices.*
FDA Label Image

Nilotinib200mgwalletcarton (Nilotinib200mgwalletcarton)

Nilotinib200mgwalletcarton (Nilotinib200mgwalletcarton)
Wallet pack carton for Nilotinib Capsules 200 mg by Camber Pharmaceuticals, Inc. The packaging indicates oral capsules with each containing 227.380 mg nilotinib hydrochloride dihydrate equivalent to 200 mg nilotinib. The carton includes dosage storage instructions and warnings about taking capsules on an empty stomach. The package contains 4 individual blister packs, each with 28 capsules.*
FDA Label Image

Nilotinib200mgwalletpack (Nilotinib200mgwalletpack)

Nilotinib200mgwalletpack (Nilotinib200mgwalletpack)
Packaging label for Nilotinib Capsules 200 mg oral capsules by Camber Pharmaceuticals, Inc. The label includes dosage instructions to take capsules on an empty stomach, patient medication guide reference, and details for a 28-capsule count blister pack. The label also features push-to-open blister pack illustrations for capsule access.*
FDA Label Image
FDA Label Image

Nilotinibchemicalstructure (Nilotinibchemicalstructure)

Nilotinibchemicalstructure (Nilotinibchemicalstructure)
Chemical structure diagram of nilotinib hydrochloride dihydrate showing its molecular composition and arrangement of atoms in a detailed two-dimensional format.*
FDA Label Image

Nilotinibfigure1 (Nilotinibfigure1)

Nilotinibfigure1 (Nilotinibfigure1)
A Kaplan-Meier survival curve graph depicting treatment-free survival percentage over time in weeks since treatment-free remission (TFR) for Nilotinib. The graph includes data on censored observations and the number of patients at risk, events, and censored cases at various time points through approximately 144 weeks.*
FDA Label Image

Nilotinibfigure2 (Nilotinibfigure2)

Nilotinibfigure2 (Nilotinibfigure2)
A Kaplan-Meier survival curve graph showing treatment-free survival percentage over time in weeks since treatment-free remission (TFR). The graph includes a solid survival curve with dashed confidence interval lines, censored observations marked, and a timeline with the number of patients at risk and events. It depicts survival analysis data commonly used in clinical trials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.